Korea M&A Corporation

HONG KONG — Singapore Airlines was rebuffed Tuesday in an effort to take a stake in China Eastern Airlines in a move that could remake the shape of China’s aviation industry with the possible emergence of one dominant Chinese carrier. A decision by minority shareholders of China Eastern to reject a tie-up with Singapore Airlines and a Singapore government investor has set the stage for an unusua..

SOUTH Korea's largest retailer Lotte Shopping Co plans to acquire a stake in a Chinese discount-store chain to expand its presence on the Chinese mainland, the Seoul-listed company said in a regulatory filing yesterday. Lotte agreed to buy a 49-percent stake in CTA Makro, which now operates five discount stores in Beijing and two in Tianjin, from SHV Holdings NV for 57.6 million euros (US$82.90 ..

Jakarta (ANTARA News) - PT Bank Nusantara Parahyangan said Japan's Mitsubishi UFJ Financial Group Inc and Acom Co Ltd are proposing to acquire a 75.41 pct stake in the company and will later make a tender offer for the remaining shares. In a published prospectus, Bank Nusantara said it has already signed a sales and purchase agreement with UFJ and Acom on Nov 27. No financial details were provid..

GlaxoSmithKline (GSK) and OncoMed Pharmaceuticals (OncoMed) today announced a worldwide strategic alliance to discover, develop and market novel antibody therapeutics to target cancer stem cells which are believed to play a key role in the establishment, metastasis and recurrence of cancer. The alliance with GSK will be conducted through its Center of Excellencefor External Drug Discovery (CEEDD..

South Korea's Eugene Group on Monday said it would pay Won1,950bn ($2,111bn) to take over Himart, the country's largest electronics retailer, after beating rival bidders including CCMP, TPG and MBK Partners. The deal means that the sellers - a consortium led by Affinity Equity Partners - will more than double the amount they invested in April 2005. Eugene Group, a conglomerate with logistics, fi..

Eisai said this morning that it’s dropping $3.9 billion in cash to pick up MGI Pharma, a Minnesota-based company that sells cancer drugs. Consider the deal a parachute for the company to wear when it falls off the patent cliff in 2010, as its biggest selling drug, the Alzheimer’s medicine Aricept, loses patent protection. The Japanese drug business has been struggling — prompting the nation’s he..